Elizabeth Anne Macintyre

Title: Elizabeth Anne Macintyre: Innovator in Nucleic Acid Amplification

Introduction

Elizabeth Anne Macintyre is a prominent inventor based in Meudon, France. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification. With a total of 2 patents, her work has implications for early diagnosis and treatment of lymphoproliferative disorders.

Latest Patents

Macintyre's latest patents focus on nucleic acid amplification primers for PCR-based clonality studies. These inventions are crucial for the early diagnosis of lymphoproliferative disorders. The patents provide a set of nucleic acid amplification primers that include a forward primer and a reverse primer, capable of amplifying various rearrangements associated with these disorders. The primers can be utilized in PCR-based clonality studies and for the detection of minimal residual disease (MRD). Additionally, a kit comprising at least one set of these primers is included in her inventions.

Career Highlights

Throughout her career, Elizabeth has worked with various institutions, including Erasmus Universiteit Rotterdam. Her research has significantly advanced the understanding of molecular diagnostics and has contributed to the development of innovative solutions in the medical field.

Collaborations

One of her notable collaborators is Anthonie Willem Langerak. Their joint efforts have furthered research in the area of lymphoproliferative disorders and have led to impactful advancements in diagnostic methodologies.

Conclusion

Elizabeth Anne Macintyre's contributions to nucleic acid amplification and molecular diagnostics highlight her role as a leading inventor in her field. Her work continues to influence early diagnosis and treatment strategies for critical health conditions.